Page 2 - அகஸ்டா பல்கலைக்கழகம் மருத்துவ கல்லூரி ஆஃப் ஜார்ஜியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
ESMO 2021: Efficacy and Safety of Relugolix vs Leuprolide in Men with Advanced Prostate Cancer: Clinical Subgroup Analysis from the Phase 3 HERO Study
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.
AUA 2021: Bladder Cancer: What is New in Biomarkers?
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.
Medfluencer: From Med Student to YouTube Star: Meet America Revere, MD
medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
AU/UGA Medical Partnership welcomes largest class
uga.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uga.edu Daily Mail and Mail on Sunday newspapers.
EAU 2021: There Is No Role for Radical Cystectomy in cT0 After Neoadjuvant Chemotherapy
(UroToday.com) At the European Association of Urology 2021 Meeting’s controversies in Onco-Urology session, Dr. Alexandra Masson-Lecomte discussed that there is no role for radical cystectomy in cT0 disease after neoadjuvant chemotherapy.
Dr. Masson-Lecomte noted that up to 5-15% of patients will have T0 disease after TURBT alone, which increases to 25-38% after MVAC after neoadjuvant chemotherapy based an analysis of the Nordic I, Nordic II, SWOG, and MRC trials.
1 More recently, presented at the ASCO GU 2020 meeting, preliminary results from the randomized phase III GETUG/AFU VESPER trial for treatment of muscle-invasive urothelial bladder cancer showed that with dose-dense MVAC, pT0 rates of 42% are attainable.